About US
Contact us
-
Lilly aims to harmonize its social-media voicesEli Lilly ($LLY) wants to speak with one voice online. But interest in social media is growing throughout the company. So, Lilly communications specialists are working on a unified social media strate2012/7/12
-
Novartis plant snafu sends desperate Excedrin users to eBayJohnson & Johnson ($JNJ) isn't the only drugmaker struggling to get recalled over-the-counter products back on store shelves. Novartis ($NVS) hasn't yet restocked brands pulled back in January, an2012/7/11
-
FDA plan requires opioid makers to fund anti-abuse CMEMaking strong painkillers now comes with extra responsibility. The FDA has unveiled new measures aimed at nipping opioid abuse in the bud. They require drugmakers to fund educational courses for doc2012/7/11
-
BMS, Lilly's targeted drug Erbitux gets new FDA nodErbitux from Bristol-Myers Squibb ($BMY) and Eli Lilly ($LLY) has received a new first-line approval for targeted use against colorectal cancer. The agency OK comes along with approval for a companion2012/7/10
-
Natco's generic of Bayer's Nexavar hits India marketNatco Pharma's generic version of Bayer'sNexavar has hit the market in India, a gift to poor Indians from the government patent office in a move threatening international repercussions. A Natco execu2012/7/10
-
Pfizer trimming health claims on CentrumWhether Pfizer ($PFE) is bowing to pressure from a public interest group or ducking for cover for questionable advertising, it says it has decided within the next month to remove some health claims fr2012/7/9
-
K-V says it will go bankrupt without FDA interventionK-V Pharmaceutical ($KV.A) claims in a lawsuit that if the FDA does not allow it to exclusively make the premature birth drug Makena and charge 35 times more per injection than compounders, its busine2012/7/9
-
Genentech's R&D takes the prize at RocheWhen Roche ($RHHBY) bought out Genentech back in 2009, analysts fretted over the looming culture clash as the corporate types of Basel invaded San Francisco. But the real showdown was taking place bet2012/7/4
-
U.K. to spend less on branded drugs, report findsDrugmakers can't get a break in Europe these days. Bad debt in Greece and Spain. Price cuts not only in troubled southern Europe, but Germany and France, too. And now, a report shows that U.K. spendin2012/7/4
-
New week, new winner in the top pharma settlements contestLast week, when we unveiled our Top 10 Pharma Settlements report, we promised to update it as new deals hit the news. We didn't realize we'd need to fulfill that promise so quickly. Today, GlaxoSmithK2012/7/3